C-C motif ligand 5 promotes migration of prostate cancer cells in the prostate cancer bone metastasis microenvironment

A mechanically active heterotypic E-cadherin/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion

(2017) Anna Labernadie et al.   NATURE CELL BIOLOGY

Tumor-associated macrophages promote prostate cancer migration through activation of the CCL22–CCR4 axis

(2016) Aerken Maolake et al.   Oncotarget

Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer

(2015) Giorgio Gandaglia et al.   EUROPEAN UROLOGY

The β-catenin signaling pathway induces aggressive potential in breast cancer by up-regulating the chemokine CCL5

(2015) Rika Yasuhara et al.   EXPERIMENTAL CELL RESEARCH

The relationship between prostate-specific antigen and TNM classification or Gleason score in prostate cancer patients with low prostate-specific antigen levels

(2015) Kouji Izumi et al.   PROSTATE

Validation of TNM classification for metastatic prostatic cancer treated using primary androgen deprivation therapy

(2015) Yoshifumi Kadono et al.   WORLD JOURNAL OF UROLOGY

Infiltrating bone marrow mesenchymal stem cells (BM-MSCs) increase prostate cancer cell invasion via altering the CCL5/HIF2α/androgen receptor signals

(2015) Jie Luo et al.   Oncotarget

Serum chemokine (CC motif) ligand 2 level as a diagnostic, predictive, and prognostic biomarker for prostate cancer

(2015) Kouji Izumi et al.   Oncotarget

Outcomes and predictive factors of prostate cancer patients with extremely high prostate-specific antigen level

(2014) Kouji Izumi et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Targeting inflammatory cytokines-androgen receptor (AR) signaling with ASC-J9®to better battle prostate cancer progression

(2014) Kouji Izumi et al.   OncoImmunology

Infiltrating Macrophages Promote Prostate Tumorigenesis via Modulating Androgen Receptor-Mediated CCL4-STAT3 Signaling

(2013) L.-Y. Fang et al.   CANCER RESEARCH

CCR1/CCL5 interaction promotes invasion of taxane-resistant PC3 prostate cancer cells by increasing secretion of MMPs 2/9 and by activating ERK and Rac signaling

(2013) Taku Kato et al.   CYTOKINE

Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation

(2013) Kouji Izumi et al.   EMBO Molecular Medicine

Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling

(2013) J Luo et al.   ONCOGENE

Exogenous SPARC Suppresses Proliferation and Migration of Prostate Cancer by Interacting With Integrin β1

(2013) Minkyoung Shin et al.   PROSTATE

Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling

(2013) T-H Lin et al.   Cell Death & Disease

Prostate Cancer Cells and Bone Stromal Cells Mutually Interact with Each Other through Bone Morphogenetic Protein-mediated Signals

(2012) Hikaru Nishimori et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor β1-associated osteoblastic changes

(2009) Kouji Izumi et al.   PROSTATE